Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer

Clinical trial NCT03187314 · COMPLETED

Trial details

NCT number: NCT03187314
Sponsor: Hangzhou Cancer Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Neoplasms Esophageal Diseases Esophageal Squamous Cell Carcinoma

Start date: 2017-06-14
Primary completion: 2019-06-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.